Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Breast Neoplasms 1

Interventions

Radiotherapy 3Vincristine 2Rituximab 2Prednisone 2Methotrexate 2Doxorubicin 2Cyclophosphamide 2merphos 1liposomal amphotericin B 1ixabepilone 1fludarabine 1denileukin diftitox 1bismuth tripotassium dicitrate 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Tetracycline 1Tazobactam 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Photopheresis 1Pharmacogenomic Testing 1Pentostatin 1Palliative Care 1Omeprazole 1Nutritional Support 1Nicotine 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, B-Cell, Marginal Zone × Tetracycline × Clear all
NCT00003151 2012-07-02

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
96 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡